Do you think that if we get positive results in the P2 trials for 2591, the market might take the view that there will be a similar outcome to Trofinetide and that it will pass P3?
- Forums
- ASX - By Stock
- NEU
- Wilsons target $18.29 and summary
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.50%
!
$14.09

Wilsons target $18.29 and summary, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.09 |
Change
0.070(0.50%) |
Mkt cap ! $1.766B |
Open | High | Low | Value | Volume |
$13.90 | $14.21 | $13.64 | $2.368M | 170.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 505 | $14.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.11 | 110 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 233 | 14.110 |
1 | 136 | 14.100 |
3 | 676 | 14.090 |
8 | 984 | 14.080 |
4 | 1215 | 14.070 |
Price($) | Vol. | No. |
---|---|---|
14.130 | 250 | 3 |
14.140 | 596 | 6 |
14.150 | 502 | 3 |
14.160 | 1095 | 6 |
14.170 | 1167 | 5 |
Last trade - 12.54pm 08/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |